Shukla Sanjay (CIK 1671026) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-04). Recent activity: Buy ATYR (10,375 shares), Sell ATYR (3,745 shares), Buy ATYR (10,375 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-04 | aTYR PHARMA INC (ATYR) | President and CEO | Buy | 10,375 | $0 |
| 2026-02-04 | aTYR PHARMA INC (ATYR) | President and CEO | Sell | 3,745 | $3,670 |
| 2025-02-04 | aTYR PHARMA INC (ATYR) | President and CEO | Buy | 10,375 | $0 |
Source: SEC Form 4 filings · as of 2026-02-04